Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors

Details for Australian Patent Application No. 2002233558 (hide)

Owner MELACURE THERAPEUTICS AB

Inventors Hallberg, Anders; Hallgren, Anneli; Lundstedt, Torbjorn; Andersson, Per; Nordberg, Malin Graffner

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002233558

PCT Pub. Number WO2002/068397

Priority 0100694-9 28.02.01 SE; 0200008-1 02.01.02 SE

Filing date 28 February 2002

Wipo publication date 12 September 2002

International Classifications

C07D 239/95 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 031/505 - Pyrimidines

A61P 035/00 Antineoplastic agents

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002233558

24 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002233559-HIERARCHICHAL LANGUAGE MODELS

2002233557-IMMUNE RESPONSE POTENTIATION